Effectiveness of inspiratory muscle training in patients with a chronic respiratory disease: an overview of systematic reviews

dc.contributor.author
Torres Castro, Rodrigo
dc.contributor.author
Caicedo Trujillo, Saul
dc.contributor.author
Gimeno Santos, Elena, 1980-
dc.contributor.author
Gutiérrez Arias, Ruvistay
dc.contributor.author
Alsina Restoy, Xavier
dc.contributor.author
Vasconcello Castillo, Laura
dc.contributor.author
Seron, Pamela
dc.contributor.author
Spruit, Martijn A.
dc.contributor.author
Blanco Vich, Isabel
dc.contributor.author
Vilaró, Jordi
dc.date.accessioned
2025-12-17T19:03:35Z
dc.date.available
2025-12-17T19:03:35Z
dc.date.issued
2025-12-16T15:01:17Z
dc.date.issued
2025-12-16T15:01:17Z
dc.date.issued
2025-05-21
dc.date.issued
2025-12-16T15:01:19Z
dc.identifier
https://hdl.handle.net/2445/224990
dc.identifier
762433
dc.identifier
40469386
dc.identifier.uri
http://hdl.handle.net/2445/224990
dc.description.abstract
Introduction: There has been inconclusive findings regarding the effectiveness of inspiratory muscle training (IMT) in chronic respiratory diseases (CRDs). Our objective was to determine the effectiveness of IMT on exercise tolerance, maximum respiratory pressure, lung function, symptoms and quality of life in different CRDs. Methods: We conducted an overview of systematic reviews (SRs) in adults with CRDs who underwent IMT. We reviewed five databases in March 2025. We chose the most comprehensive SRs to report on the analysed outcomes. Results: Twenty-three SRs were included. In chronic obstructive pulmonary disease (COPD), IMT increased the six-minute walk distance (6MWD) by 35.7 m (95% CI 25.7, 45.7), maximum inspiratory pressure (MIP) by 10.9 cmH2O (95% CI 8.0, 13.9). In asthma, IMT increased the forced expiratory volume in the first second (FEV1) by 3.3%pred (95% CI 1.4, 5.1), forced vital capacity (FVC) by 4.1%pred (95% CI 1.0, 7.3), MIP by 21.9 cmH2O (95% CI 15.0, 28.8), and dyspnoea was reduced (standard mean difference -0.8, 95% CI -1.3,-0.2). In obstructive sleep apnoea (OSA), IMT increased MIP by 29.6 cmH2O (95% CI 6.0, 53.1). In pulmonary hypertension (PH), IMT increased 6MWD by 39.0 m (95% CI 20.7, 57.4), MIP in 21.2 cmH2O (95% CI 11.3, 31.1), maximum expiratory pressure by 14.4 cmH2O (95% CI 6.9, 21.9), and dyspnoea was reduced by 0.5 (95% CI 0.1, 0.9) in modified Medical Research Council scale. In lung resection (LR), IMT increased MIP by 8.1 cmH2O (95% CI 1.3, 14.9). In bronchiectasis, IMT increased MIP by 6.1 cmH2O (95% CI 1.4, 10.8). Overall, the most consistent effect of IMT across different CRDs was an increase in MIP. Conclusion: IMT improved several clinically relevant outcomes, including MIP, exercise capacity, and dyspnoea in different CRDs. However, the limited evidence for certain outcomes and populations highlights the need for further high-quality studies.
dc.format
13 p.
dc.format
application/pdf
dc.language
eng
dc.publisher
Frontiers Media
dc.relation
Reproducció del document publicat a: https://doi.org/10.3389/fspor.2025.1549652
dc.relation
Frontiers in Sports and Active Living, 2025, vol. 7
dc.relation
https://doi.org/10.3389/fspor.2025.1549652
dc.rights
cc-by (c) Torres Castro, Rodrigo et al., 2025
dc.rights
http://creativecommons.org/licenses/by/4.0/
dc.rights
info:eu-repo/semantics/openAccess
dc.subject
Músculs respiratoris
dc.subject
Exercicis respiratoris
dc.subject
Malalties de l'aparell respiratori
dc.subject
Respiratory muscles
dc.subject
Breathing exercises
dc.subject
Respiratory diseases
dc.title
Effectiveness of inspiratory muscle training in patients with a chronic respiratory disease: an overview of systematic reviews
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion


Files in this item

FilesSizeFormatView

There are no files associated with this item.